The
McCabe Companies
Artist Rendering
The Neurological Disorder Center
The Neurological Disorder Center Designs Itself To Be A Leader in
The Care For People Suffering
With a Neurological Disorder Such
As Alzheimers, stroke, dementia, epilepsy, parkinsons, ALS,
multiple sclerosis, and
neuromuuscular diseases.
The McCabe Companies of The Digestive Disease Center and our Neurological
Disorder Project are Proud To Announce
Our Referral Process With Baylor College
Of Medicine.
Our Project will strive to provide excellence in
personalized health care and will offer you access to
some of the finest doctors working in their fields.
Are you in the Texas Gulf coast area and are in need
of the best care in the region? Please contact us and
we will facilitate the best care you can find.
Our association with Baylor College Of Medicine
is
designing a program like no other in the nation, and our process of care for you will provide you with a team of care givers that will deliver that level of excellence to you.
In our program, your case will be followed by:
Dr. Daniel Yoshor, M.D.
Associate Professor
Director, Epilepsy Surgery Program
Associate Residency Program Director
Board Certification American Board of Neurological Surgeons
Medical School: The University of Chicago Pritzker School, Chicago, IL
Internship: Baylor College of Medicine, Houston, TX
Residency: Baylor College of Medicine, Houston, TX
Fellowship: University of California, San Francisco, CA
Primary Neurosurgical Interests:
Clinical: Brain Tumors in Eloquent Locations, Epilepsy Surgery, Brain Mapping, Acoustic Neuroma, Endoscopic Pituitary Surgery, Meningioma, Trigeminal Neuralgia, Stereotactic Radiosurgery
Research: Human Brain Mapping, Object Recognition in Visual Cortex, Link Between Human
Neurophysiology and Perceptual Performance, Cortical Stimulation, Neuromodulation for Epilepsy
Professional Associations
American Association of Neurological Surgeons, Congress of Neurological Surgeons, Society for Neuroscience, American Epilepsy Society, Houston Neurological Society.
Recent Publications:
Yoshor D, Bosking W, Ghose G, Maunsell JHM. Receptive Fields
in Human Visual Cortex Mapped with Surface Electrodes.
Cerebral Cortex 2007; 17:2293-2302.
Yoshor D, Bosking WH, Ghose GM, Sun P, Maunsell JHR.
Electrophysiological responses in early human visual cortex are not strongly effected by attention. Journal of Neuroscience 2007; 27(48):13205-9.
in the Human Anterior Color Center. Current Biology 2008; 18(3):216-20.
Computer-controlled electrical stimulation for mapping function in human cerebral cortex. Journal of Neurosurgery, in press
Dr. Mary Ellen Vanderlick
Mary Ellen Vanderlick, MD
Alpert & Sermas Neurological
Graduation: La State Univ Sch Of Med In
Shreveport, Shreveport La 71130, (1993)
Residency: Baylor Coll Of Med, Neurology;
Baylor Coll Of Med, Flexible Or Transitional Year
Dr. Charles Brunicardi
Dr. Charles Brunicardi is the DeBakey/Bard Professor and Chair of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine since April 1999. He joined the Baylor faculty in 1995 as a Professor of Surgery and as the George Jordan Professor and Chief of the Division of
General Surgery. Dr. Brunicardi has served as the Chief of Surgical Services and the Chief of the Clinical General Surgery Service at Methodist Hospital from 1995-2004, as well as Executive Director of the Multi-Organ Transplant Center from 1995-1999. He is also a consultant and attending surgeon at the Michael E. DeBakey Veterans Affairs Medical Center, Ben Taub General Hospital, and St. Luke’s Episcopal Hospital.
Dr. Brunicardi’s areas of specialty include gastroenterology, pancreas cancer, breast cancer, and minimally invasive surgery.
We are also very proud of the addition of
Dr. Joel Joselevitz:
Dr. Joel Joselevitz, MD, PA
Dr. Joselevitz is a native of Mexico, where he graduated from medical school and performed a year of residency. He went on to serve a year of internship and three years of residency in New Jersey. He established a private practice in 1992, during which time he was also the medical director of Warm Springs Rehabilitation Hospital for three years.
Dr. Joselevitz is board certified in physical medicine and rehabilitation and pain medicine. He has published several articles in professional journals and is a member of the American Academy of Physical Medicine and Rehabilitation, the Harris County Medical Society, the Texas Medical Association, the ISIS, the Interventional Spine Injection Society and the Texas Pain Society.
Glenn R. Cunningham, M.D.
Professor of Medicine and Molecular & Cellular BiologyEducation
M.D.: University of Oklahoma Medical School, 1966
Residency:
1966-1967 Straight Medical Internship, Duke University Medical Center
1967-1968 Junior Assistant Residency (Medicine), Duke University Medical Center
1968-1970 Endocrinology Fellowship, Duke University Medical Center
1970-1971 Chief Resident in Medicine, VA Hospital, Durham, North Carolina
Research Interests
Androgen deficiency
Prostate cancer
Benign prostatic hyperplasia
Diabetes
Recent Publications
Shao TC, Li H, BS; Ittmann M, Cunningham GR. Effects of Dutasteride on Prostate Growth in the Large Probasin-Large T Antigen Mouse Model of Prostate Cancer. J Urol. 2007;178:1521-7.
Tung DS, Cunningham GR. Androgen Deficiency in Men. The Endocrinologist 2007;17:101–115.
Sanjay N. Mediwala, MD and Glenn R. Cunningham, MD. Endocrine Evaluation of Male Sexual Function. In: Textbook of Erectile Dysfunction. Edited by Culley Carson, Roger Kirby, Irwin Goldstein. In Press.
Cunningham GR. Late-Onset Hypogonadism. Medscape. In Press
Shao TC, Li H, Kasper S, Matusik R, Ittmann M, Cunningham GR. Comparison of the Growth-Promoting Effects of Testosterone and 7-|*alpha*|-Methyl-19-Nor-Testosterone (MENT) on the Prostate and Levator Ani Muscle of LPB-Tag Transgenic Mice. Prostate. 2006;66:369-76.
Garcia JM, Epner D, Hayes T, Mann D, Li H, Marcelli M, Cunningham GR. Hypogonadism in male patients with cancer. Cancer. 2006;106:2583-91.
Bhasin S, Cunningham GR, Hayes F, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.. J Clin Endocrinol Metab, 2006;91:1995-2010.
Marcelli M, Cunningham GR, Garcia JM, Lo KC, Lamb DJ. Chapter 45. Molecular Endocrinology of the Testis. In: Principles of Molecular Medicine. 2nd Edition. Eds: Runge MS, Patterson C., Humana Press, Totowa, NJ, 2006.
Cunningham GR. Testosterone replacement therapy for late-onset hypogonadism. Nat Clin Prac Urol. 2006;3:260-7.
Schenk E, Tung DS, Soodini G, Cunningham GR. Diagnosis and Management of Hyperthyroidism. Emergency Medicine 2006;38:21-38.
Hijazi R, Cunningham GR. Andropause in Human Aging. P. Michael Conn, editor. In: Handbook of Models for Human Aging. Elsevier/Academic Press, San Diego, CA, 2006, Chapter 63, pp. 749-758.
Garcia JM, Garcia-Touza M, Hijazi R, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M. Active Ghrelin Levels And Active/Total Ghrelin Ratio In Cancer-Induced Cachexia. J Clin Endocrinol Metab. 2005;90:2920-6.
13. Hijazi RA, Cunningham GR. Andropause: Is Androgen Replacement Therapy Indicated for the Aging Male. Annu Rev Med. 2005;56:117-37.
14. Crumpler CD, Hijazi R, Cunningham GR. Male Sexual Dysfunction: An Individualized Approach. Emergency Medicine 2005;37:9-18.
The committment to excellence of your
care will be provided by other members
of the Baylor Team and the patient
advocacy of The McCabe Companies as well.
Email: McCabe Companies
Phone: 832.221.3209
Our Mission
The mission of the Neurological Disorder Project is to translate advances in the basic science laboratory into meaningful therapy for the neurological afflictions of patients.
In the past several years, we have seen an explosion of new knowledge and understanding of the biochemical, physiological, pharmacological, and molecular make-up of the nervous system. These basic science advances have led to new ways of diagnosing human neurological disease, new methods for treating previously untreatable diseases, and new insights into the effective control of stroke, dementia, epilepsy, parkinsonism, ALS, multiple sclerosis, Alzheimer's disease, and neuromuscular diseases. Our primary goal at the project is to continue these advances through basic research and intensive educational activities, and to integrate them
into patient care. Through this approach, we will achieve excellence in the clinical, research, and educational inquiry into the human brain and nervous system.
The Center will facilitate excellence in on-going Neurological Disorder care, research, promote translational research between basic care and clinical areas, develop new projects, nurture new investigators, and provide educational activities. The NDC will pursue excellent patient care as it's main goal. Pilot/Feasibility and Enrichment Programs to support innovative ideas and new investigators in Neurological Disease research and foster collaboration are a key part of our Center. The Center will draw together a multidisciplinary group of doctors, nurses, investigators, including basic scientists with proven track records of success, and well-coordinated clinical programs dealing with pediatric and adult patients.
Center leaders are to be senior doctors-administrators experienced in directing interactive, multidisciplinary programs. A large, multi-ethnic population of infants through adults emphasizes the need and the opportunities for this Center. Various groups involved in research and education in the Medical Center Area of Houston, or of The Woodlands will be working with the Center.
It Doesn't Feel Like A Brain Tumor
All I know is I don't feel well; I think I am just stressed and worn out. Maybe a heart attack or stroke is coming on slowly, but no, I don't feel like I have a brain tumor. The doctor admits me to a 24-hour observation unit and orders coronary tests, and to watch me as a slightly altered fellow as well.
The doctor brings in the news; not to worry, but I have a small, barely visible brain tumor and he can treat it with medicine. Wow the things they can do these days!!!
Six months later, I've gotten a bit confused, I’m stuttering oddly, my body is jerking, my muscles contracting, and am experiencing tremors that are very pronounced.
We go to a different hospital and a neurologist came in and pronounced that my once tiny brain tumor is now "massive and bleeding." At this point, my wife Beth is the one who looks like she has a brain tumor and our daughter Claire asks what the doctors are going to do. The neurologist says he is bringing in their esteemed neurosurgeon to consult with and to determine our best course of action. He leaves and returns a short while later to tell us their esteemed team of neurosurgeons has refused to treat me, as it looks much too difficult for them.
There are new doctors and nurses are all around me; they assure me there are no olives or movies and that they will be able to take care of me. Maybe a fine cabernet then, with a Caesar salad…wow, this doctor is literally right next to my face, I ask if I should have chardonnay instead.
I awake. Beth is asking me how I can sleep at a time like this. I ask, “What time is it?” Another doctor looks at me and tells me they will be going through my nose and between my lip and gums in an attempt to remove as much of the tumor as they can. I ask, “Does this mean there are no olives here either?”
As I awake from surgery, I find that I am restrained and my face is numb. There are a number of tubes coming out of me. My wife Beth and our wonderful friend from church, Elaine are watching me and I say “what’s up?” at which point Beth begins to cry and I wonder what I’ve done now. But it all starts to come back to me, as I realize my nose seems to be quite a bit bigger (which is saying something if you’ve seen my nose!) my mouth is numb, my tongue is thick, but the room, is beautiful.
The doctors and nurses of St. Lukes hospital and Baylor College of Medicine have done what they do every day…the absolute best care they can provide and saving lives.
Dr. Yosher removed 90% of my tumor. I was tested and retested and “considering the magnitudeof my tumor” I am in great condition. The doctors are now able to control the remainder of my tumor with medication and, although I still have symptoms, I don’t stress over the movies they have on buses, or the lack of olives (actually I don’t drink anymore….that is the worst part of this whole ordeal.)
The opportunity to refer patients to these fine people is very exciting. I am very proud to have “worked” with them and know they will give the best care available to any they serve.
Top